These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22792665)

  • 21. Prescription database: a new tool in drug fight.
    Gadea J
    Conn Med; 2010 Mar; 74(3):169-70. PubMed ID: 20391826
    [No Abstract]   [Full Text] [Related]  

  • 22. Doctor and pharmacy shopping for controlled substances.
    Peirce GL; Smith MJ; Abate MA; Halverson J
    Med Care; 2012 Jun; 50(6):494-500. PubMed ID: 22410408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Misuse of psychotropic substances: outline and recommendations of a conference held in London in March 1980.
    Ghodse AH; Khan I
    Bull Narc; 1982; 34(3-4):83-90. PubMed ID: 6926514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New Drug Enforcement Administration guideline for communicating controlled substance prescriptions to pharmacies.
    Drug Enforcement Adminstration U S Department of Justice
    J Pain Palliat Care Pharmacother; 2011; 25(1):83-9. PubMed ID: 21426229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resting assured: risk management in the prescription of controlled substances.
    Longo LP
    WMJ; 1999; 98(1):23-9. PubMed ID: 10050150
    [No Abstract]   [Full Text] [Related]  

  • 26. A flood of opioids, a rising tide of deaths.
    Okie S
    N Engl J Med; 2010 Nov; 363(21):1981-5. PubMed ID: 21083382
    [No Abstract]   [Full Text] [Related]  

  • 27. Deregulating mandatory medical prescription.
    Mitchell CN
    Am J Law Med; 1986; 12(2):207-39. PubMed ID: 3327377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prescribing controlled drugs.
    Cohen J
    Practitioner; 1991 May; 235(1502):452-4. PubMed ID: 1924129
    [No Abstract]   [Full Text] [Related]  

  • 29. Commentary in response to Paulozzi et al.: prescription drug abuse and safe pain management.
    Fishman SM
    Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):628-31. PubMed ID: 16862601
    [No Abstract]   [Full Text] [Related]  

  • 30. Prescription Drug Abuse Task Force recommendations.
    Prescription Drug Abuse Task Force
    J Ky Med Assoc; 2003 Nov; 101(11):495-7. PubMed ID: 14635577
    [No Abstract]   [Full Text] [Related]  

  • 31. Prescription drug abuse does not discriminate.
    Lovedale L
    Colo Nurse; 2014 May; 114(2):7. PubMed ID: 25118430
    [No Abstract]   [Full Text] [Related]  

  • 32. The Minnesota Prescription Monitoring Program.
    Herman C
    Northwest Dent; 2011; 90(2):33-5. PubMed ID: 21667591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prescribing issues grant report to the Board of Medical Examiners. II. Minnesota Medical Association.
    Minn Med; 1990 Aug; 73(8):36-42. PubMed ID: 2398844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prescription drug abuse and DEA-sanctioned drug take-back events: characteristics and outcomes in rural Appalachia.
    Gray JA; Hagemeier NE
    Arch Intern Med; 2012 Aug; 172(15):1186-7. PubMed ID: 22733245
    [No Abstract]   [Full Text] [Related]  

  • 35. Fifteen solutions to the problems of prescription drug abuse.
    Lurie P; Lee PR
    J Psychoactive Drugs; 1991; 23(4):349-57. PubMed ID: 1813607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controlling prescription of benzodiazepines.
    Appelbaum PS
    Hosp Community Psychiatry; 1992 Jan; 43(1):12-3. PubMed ID: 1347509
    [No Abstract]   [Full Text] [Related]  

  • 37. Update: Colorado Prescription Drug Abuse Coalition.
    Colo Med; 1985 Jan; 82(1):13-4. PubMed ID: 3971676
    [No Abstract]   [Full Text] [Related]  

  • 38. PADS: a program to identify and diagnose prescription drug diversion in Indiana.
    Indiana Med; 1987 Sep; 80(9):874-6. PubMed ID: 3668236
    [No Abstract]   [Full Text] [Related]  

  • 39. Should physicians' self-prescribing be restricted by law?
    Rosvold EO; Tyssen R
    Lancet; 2005 Apr 16-22; 365(9468):1372-4. PubMed ID: 15836873
    [No Abstract]   [Full Text] [Related]  

  • 40. Programs for monitoring inappropriate prescribing of controlled drugs: evaluation and recommendations.
    Collins TM; Zimmerman DR
    Am J Hosp Pharm; 1992 Jul; 49(7):1765-8. PubMed ID: 1621738
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.